Cancer Vaccines and Immune Modulation

Cancer vaccines and immune modulation represent groundbreaking advances in oncology. Therapeutic vaccines aim to stimulate the immune system to recognize and attack cancer cells, while prophylactic vaccines, like those against HPV, prevent infection-associated cancers. Immune modulation, involving checkpoint inhibitors and adoptive cell therapies, enhances the body’s natural defense mechanisms against tumors. These approaches have shown remarkable success in treating certain cancers, such as melanoma and lung cancer. Continued research in immunotherapy is expanding its applicability to a broader range of malignancies, offering new hope for patients worldwide.